ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Pharmacology of Anti-Cancer Drugs
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1586494
This article is part of the Research TopicDemystifying Fundamental Mechanisms of anticancer drug resistance in Gastrointestinal OncologyView all 5 articles
Identification and prognostic value of tryptophan metabolism-related genes in gastric carcinogenesis
Provisionally accepted- Affiliated Hospital, Ningbo University, Ningbo, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Gene regulation and functional mechanisms of tryptophan metabolites in gastric carcinogenesis and their clinical importance have not been fully elucidated. Functional enrichment of tryptophan metabolism-associated differential genes was filtered and analyzed from databases. A prognostic risk model containing 11 metabolism-associated genes (MAGs) was established using Lasso-Cox regression. The association of key genes with immune cell infiltration, drug sensitivity, specific signaling pathways, prognostic prediction and miRNA regulatory networks was investigated. CellChat was utilized to analyze differences in cell subpopulations and cell communication between high-risk and low-risk groups as well as the variations in exhaustion factor scores and cytokine scores in single cells. Expression levels of key genes were validated through PCR in paired GC tissues, and biological functions of key genes were verified in vitro experiments. Total 11 key prognostic genes, GLA, MALAT1, TCIRG1, NMB, HBA2, HBB, ANXA5, RNASE1, APOD, NRP1 and ZFP36, that are involved in tryptophan metabolism of GC were identified. Additionally, a prognostic model associated with tryptophan metabolism in GC was constructed. The prognostic risk model was an independent prognostic factor that not only effectively distinguished patients in the high-risk group from those in the low-risk group but also significantly correlated with patients' clinical prognosis, tumor immune microenvironment, sensitivity to chemotherapeutic agents and clinically important indicators. The risk model has been validated across multiple datasets, and its predictive analysis results were consistent with bioinformatics analysis, demonstrating the robustness and accuracy of the tryptophan metabolism-related GC prognostic model. Knocking down APOD and TCIRG1 expression significantly inhibited cell proliferation, colony formation and invasion of GC. Our study explored a prognostic model and molecular network mechanism associated with tryptophan metabolism in GC using multiple datasets to facilitate a novel perspective on the pathogenesis, clinical diagnosis, treatment and prognostic evaluation of GC.
Keywords: tryptophan metabolism, gastric cancer, Prognostic risk model, Tumor immune microenvironment, ApoD, TCIRG1
Received: 03 Mar 2025; Accepted: 24 Apr 2025.
Copyright: © 2025 Shao, Dong, Yu, Ye and Yan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Jianing Yan, Affiliated Hospital, Ningbo University, Ningbo, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.